Dare Bioscience Stock Buy Hold or Sell Recommendation
| DARE Stock | USD 2.40 0.01 0.42% |
Given the investment horizon of 90 days and your above-average risk tolerance, our recommendation regarding Dare Bioscience is 'Strong Sell'. Macroaxis provides Dare Bioscience buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding DARE positions. Check out Dare Bioscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Dare Stock refer to our How to Trade Dare Stock guide. Note, we conduct extensive research on individual companies such as Dare and provide practical buy, sell, or hold advice based on investors' constraints. Dare Bioscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Execute Dare Bioscience Buy or Sell Advice
The Dare recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Dare Bioscience. Macroaxis does not own or have any residual interests in Dare Bioscience or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Dare Bioscience's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Sell
Market Performance | Weakest | Details | |
Volatility | Very risky | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Small | Details | |
Economic Sensitivity | Almost neglects market trends | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Unavailable | Details |
Dare Bioscience Trading Alerts and Improvement Suggestions
| Dare Bioscience generated a negative expected return over the last 90 days | |
| Dare Bioscience has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 9.78 K. Net Loss for the year was (4.05 M) with loss before overhead, payroll, taxes, and interest of (13.22 M). |
Dare Bioscience Returns Distribution Density
The distribution of Dare Bioscience's historical returns is an attempt to chart the uncertainty of Dare Bioscience's future price movements. The chart of the probability distribution of Dare Bioscience daily returns describes the distribution of returns around its average expected value. We use Dare Bioscience price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Dare Bioscience returns is essential to provide solid investment advice for Dare Bioscience.
| Mean Return | -0.21 | Value At Risk | -7.75 | Potential Upside | 5.16 | Standard Deviation | 4.27 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Dare Bioscience historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Dare Bioscience Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Dare Bioscience or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Dare Bioscience's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Dare stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.18 | |
β | Beta against Dow Jones | -0.37 | |
σ | Overall volatility | 4.27 | |
Ir | Information ratio | -0.08 |
Dare Bioscience Volatility Alert
Dare Bioscience exhibits very low volatility with skewness of 2.13 and kurtosis of 13.1. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Dare Bioscience's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Dare Bioscience's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Dare Bioscience Fundamentals Vs Peers
Comparing Dare Bioscience's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Dare Bioscience's direct or indirect competition across all of the common fundamentals between Dare Bioscience and the related equities. This way, we can detect undervalued stocks with similar characteristics as Dare Bioscience or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Dare Bioscience's fundamental indicators could also be used in its relative valuation, which is a method of valuing Dare Bioscience by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Dare Bioscience to competition |
| Fundamentals | Dare Bioscience | Peer Average |
| Return On Equity | -9.95 | -0.31 |
| Return On Asset | -0.87 | -0.14 |
| Operating Margin | (180.17) % | (5.51) % |
| Current Valuation | 14.4 M | 16.62 B |
| Shares Outstanding | 8.85 M | 571.82 M |
| Shares Owned By Insiders | 1.56 % | 10.09 % |
| Shares Owned By Institutions | 9.34 % | 39.21 % |
| Number Of Shares Shorted | 1.11 M | 4.71 M |
| Price To Earning | (43.44) X | 28.72 X |
| Price To Book | 10.75 X | 9.51 X |
| Price To Sales | 816.41 X | 11.42 X |
| Revenue | 9.78 K | 9.43 B |
| Gross Profit | (13.22 M) | 27.38 B |
| EBITDA | (23.41 M) | 3.9 B |
| Net Income | (4.05 M) | 570.98 M |
| Cash And Equivalents | 40.39 M | 2.7 B |
| Cash Per Share | 0.48 X | 5.01 X |
| Total Debt | 1.3 M | 5.32 B |
| Debt To Equity | 0.02 % | 48.70 % |
| Current Ratio | 2.17 X | 2.16 X |
| Book Value Per Share | (1.08) X | 1.93 K |
| Cash Flow From Operations | 5.39 M | 971.22 M |
| Short Ratio | 0.26 X | 4.00 X |
| Earnings Per Share | (0.17) X | 3.12 X |
| Target Price | 13.0 | |
| Number Of Employees | 21 | 18.84 K |
| Beta | 1.11 | -0.15 |
| Market Capitalization | 21.15 M | 19.03 B |
| Total Asset | 22.1 M | 29.47 B |
| Retained Earnings | (175.29 B) | 9.33 B |
| Working Capital | (3.16 M) | 1.48 B |
| Current Asset | 7.58 M | 9.34 B |
| Current Liabilities | 17.82 M | 7.9 B |
Note: Acquisition by Matz Gregory W of 40000 shares of Dare Bioscience at 0.96 subject to Rule 16b-3 [view details]
Dare Bioscience Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Dare . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Dare Bioscience Buy or Sell Advice
When is the right time to buy or sell Dare Bioscience? Buying financial instruments such as Dare Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Dare Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Money Market Funds Thematic Idea Now
Money Market Funds
Funds or Etfs investing in various types of short-term (less than one year) fixed income instruments of high-quality and liquidity. The Money Market Funds theme has 43 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Money Market Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Dare Bioscience Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. For information on how to trade Dare Stock refer to our How to Trade Dare Stock guide.You can also try the Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dare Bioscience. If investors know Dare will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dare Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Dare Bioscience is measured differently than its book value, which is the value of Dare that is recorded on the company's balance sheet. Investors also form their own opinion of Dare Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Dare Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dare Bioscience's market value can be influenced by many factors that don't directly affect Dare Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dare Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dare Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dare Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.